Production (Stage)
Sharp Therapeutics Corp.
SHRXF
$1.29
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.48M | -1.46M | -2.28M | -3.11M | -3.95M |
| Total Depreciation and Amortization | 76.70K | 92.00K | 93.30K | 94.60K | 125.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 192.00K | -1.17M | 110.60K | 1.39M | 1.67M |
| Change in Net Operating Assets | -547.20K | -430.60K | -170.10K | 90.40K | 106.90K |
| Cash from Operations | -3.76M | -2.97M | -2.25M | -1.53M | -2.05M |
| Capital Expenditure | 0.00 | -31.10K | -31.10K | -31.10K | -36.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.20K | 5.20K | 2.60K | -- | -- |
| Cash from Investing | 5.20K | -25.90K | -28.50K | -31.10K | -36.30K |
| Total Debt Issued | 950.00K | 950.00K | -166.10K | -1.28M | -641.10K |
| Total Debt Repaid | -386.80K | -386.80K | -268.40K | -150.00K | -200.00K |
| Issuance of Common Stock | 4.96M | 5.46M | 4.17M | 2.88M | 2.88M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 29.60K | 29.60K | 14.80K | -- | -- |
| Cash from Financing | 5.56M | 6.06M | 3.75M | 1.45M | 2.04M |
| Foreign Exchange rate Adjustments | -20.00K | 6.00K | 3.00K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.78M | 3.07M | 1.48M | -112.10K | -40.30K |